Garner Thomas 4
4 · LEXICON PHARMACEUTICALS, INC. · Filed Oct 11, 2023
Insider Transaction Report
Form 4
Garner Thomas
SVP, Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-10-09+248,923→ 248,923 totalExercise: $1.08Exp: 2033-10-09→ Common Stock (248,923 underlying)
Footnotes (1)
- [F1]Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (10/9/2024) and vests 1/48th per month for each month of service thereafter.